US Patent 7825098 Methods and compositions for modulating Necdin function
Patent 7825098 was granted and assigned to Joslin Diabetes Center (company) on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+180 characters)
Article
Patent abstract
Described herein are methods for identifying and using inhibitors of Necdin function to promote brown adipose tissue (BAT) differentiation, thereby treating obesity.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07825098 Methods and compositions for modulating Necdin function US Patent 7825098 Methods and compositions for modulating Necdin function
Infobox
Patent Number
0782509800
Patent Number
782509800
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078250980
Date of Patent
November 2, 2010
0Patent Application Number
113975140
Date Filed
April 4, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078250980
Date of Patent
November 2, 2010
0Patent Application Number
113975140
Date Filed
April 4, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07825098 Methods and compositions for modulating Necdin function
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07825098
Date of patent
November 2, 2010
Patent application number
11397514
Date Filed
April 4, 2006
Patent primary examiner
Find more entities like US Patent 7825098 Methods and compositions for modulating Necdin function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
